Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine in Neonates
NCT01159262Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jul 2010
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of dexmedetomidine in sedation, sponsored by Pfizer. Started Jul 2010; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
sedation
Beyond the preview
Go deeper on NCT01159262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01159262.